| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -3.93M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CGTX returned -65.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -27.1% |
| 1 year | -65.0% |
| All-time high | $12.09 (Oct 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CGTX would be worth today ›No. Cognition Therapeutics, Inc. has not paid a dividend in the past 12 months.
Cognition Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol CGTX.
Cognition Therapeutics, Inc. is part of the Healthcare sector.
Cognition Therapeutics, Inc. has a market cap of 93.62M USD, based on the latest quote.
